1. Signaling Pathways
  2. Apoptosis
  3. TNF Receptor
  4. TNFRSF12A/TWEAK Isoform
  5. TNFRSF12A/TWEAK Agonist

TNFRSF12A/TWEAK Agonist

TNFRSF12A/TWEAK Agonist (1):

Cat. No. Product Name Effect Purity
  • HY-P992321
    BAY-356
    Agonist
    BAY-356, a potent TWEAK receptor agonist, is an aglycosylated anti-TWEAK receptor antibody. BAY-356 triggers TWEAKR hyperactivation, activates NFκB and STAT1 pathways, and undergoes TWEAKR-dependent internalization. BAY-356 can be used for the research of colorectal cancer, bladder cancer, non-small cell lung cancer and pancreatic cancer[1][2].